Rush COVID-19 Research in the News


September 24, 2020
  • Patients with COVID-19 may have higher risk of kidney injury

    According to Jochen Reiser, MD, PhD, the Ralph C Brown MD professor and chairperson of Rush’s Department of Internal Medicine, patients with COVID-19 experience elevated levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.
June 25, 2020

News features on a review of how coughing and sneezing affect respiratory transmission of viruses, coauthored by Jie Li, PhD, RRT, associate professor, Department of Cardiopulmonary Services, Division of Respiratory Care, Rush University Medical Center

June 11, 2020
May 22, 2020
May 16, 2020
May 14, 2020
  • Low-Tech Way to Help Some Covid Patients: Flip Them Over
    The New York Times
    This exploration of proning to improve breathing in coronavirus patients quotes Sara Hanif Mirza, MD, MS on Rush’s clinical trial of the technique.
  • Study suggests a protein may predict severe COVID-19
    Medical News Today
    Jochen Reiser, MD, PhD, chairman of the Department of Internal Medicine, discusses findings by researchers at Rush University Medical Center and other institutions suggesting that a protein called suPAR could be predictive of which patients with COVID-19 might need breathing support from ventilators.
May 12, 2020
May 5, 2020
April 25, 2020
April 22, 2020
April 14, 2020
April 10, 2020


Additional media coverage will be collected here as it is published.